Literature DB >> 8305649

Phosphate kinetics during high-flux hemodialysis.

C A DeSoi1, J G Umans.   

Abstract

Phosphate clearance by polysulfone (PS) and cuprophane (CU) membranes and the relationship of peridialytic changes in serum phosphate with those of serum-ionized calcium, parathyroid hormone (PTH), and insulin were studied in six stable patients undergoing chronic hemodialysis (HD). Dietary phosphate intake was 25.7 mmol/day, and total dose of elemental calcium was 3.2 g/day. Patients were dialyzed for 2 to 4 h, once with each membrane. Serum phosphate levels fell precipitously during the first hour of HD with both dialyzers, from 1.42 and 1.49 mM to nadirs of 0.53 and 0.69 mM for PS and CU, respectively. Phosphate levels began to increase either late in HD or at the end of HD and, by 4 h post-HD, did not differ from predialysis values. Total mass transfer of phosphate was greater during the first hour (3.4 and 3.2 mmol for PS and CU, respectively) than during the remainder of HD (2.4 and 2.6 mmol/h). There were no significant differences in intradialytic serum phosphate changes, postdialytic phosphate rebound, or total phosphate removal between the two dialyzers. Ionized calcium increased by 0.11 mM, and PTH was suppressed to 40 to 50% of baseline values during dialysis with either membrane. Although phosphate removal continued for the duration of dialysis, serum phosphate did not continue to decrease, either reaching an apparent steady state or beginning to rebound, even during dialysis. This suggests active phosphate mobilization from a pool other than the extracellular fluid and demonstrates the inadequacy of a one-compartment model to explain these data. Further, these data do not support the regulation of intradialytic phosphate mobilization by serum PTH or insulin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305649     DOI: 10.1681/ASN.V451214

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  13 in total

1.  Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.

Authors:  Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

2.  A wearable artificial kidney for patients with end-stage renal disease.

Authors:  Victor Gura; Matthew B Rivara; Scott Bieber; Raj Munshi; Nancy Colobong Smith; Lori Linke; John Kundzins; Masoud Beizai; Carlos Ezon; Larry Kessler; Jonathan Himmelfarb
Journal:  JCI Insight       Date:  2016-06-02

3.  Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

Authors:  Robert E Olivo; Julia J Scialla
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

4.  Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Authors:  Baris U Agar; Alp Akonur; Ying-Cheng Lo; Alfred K Cheung; John K Leypoldt
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

Review 5.  Single needle hemodialysis: is the past the future?

Authors:  Raymond Vanholder
Journal:  J Nephrol       Date:  2019-09-19       Impact factor: 3.902

6.  Electrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis (MiD) Study.

Authors:  Simon Correa; Katherine Mikovna Scovner; James A Tumlin; Prabir Roy-Chaudhury; Bruce A Koplan; Alexandru I Costea; Vijay Kher; Don Williamson; Saurabh Pokhariyal; Candace K McClure; Finnian R Mc Causland; David M Charytan
Journal:  Kidney360       Date:  2021-04-29

7.  Hemodialysis: core curriculum 2014.

Authors:  Thomas A Golper; Rachel Fissell; William H Fissell; P Matthew Hartle; M Lee Sanders; Gerald Schulman
Journal:  Am J Kidney Dis       Date:  2013-11-19       Impact factor: 8.860

8.  Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis.

Authors:  Sandrine Lemoine; Thomas Fournier; Gabriel Kocevar; Amélie Belloi; Gabrielle Normand; Danielle Ibarrola; Dominique Sappey-Marinier; Laurent Juillard
Journal:  J Am Soc Nephrol       Date:  2015-11-11       Impact factor: 10.121

9.  Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.

Authors:  Christopher W McIntyre; Pearl Pai; Graham Warwick; Martin Wilkie; Alex J Toft; Alastair J Hutchison
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 8.237

Review 10.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.